These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35143036)

  • 41. A giant invasive macroprolactinoma with recurrent nasal bleeding as the first clinical presentation: case report and review of literature.
    Li D; Wang Y; Tan H; Luo P; Yu Y
    BMC Endocr Disord; 2023 May; 23(1):107. PubMed ID: 37173679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolactin-secreting macroadenoma in a prepubertal girl.
    Kashiwagi S; Nishizaki T; Harada K; Ito H; Setoguchi M; Takahashi M; Ishihara T
    Childs Nerv Syst; 1998 Oct; 14(10):602-5. PubMed ID: 9840387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An unusual case of Cushing's syndrome due to bihormonal ACTH-prolactin secreting pituitary macroadenoma with rapid response to cabergoline.
    Kunasegaran S; Croxson MS; Holdaway I; Murphy R
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28784879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma.
    Gillam MP; Middler S; Freed DJ; Molitch ME
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4447-51. PubMed ID: 12364416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Giant, solid, invasive prolactinoma in a prepubescent boy with gynecomastia.
    Furtado SV; Saikiran NA; Ghosal N; Hegde AS
    Pediatr Neurol; 2010 Jan; 42(1):72-4. PubMed ID: 20004869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ectopic Cavernous Sinus Microprolactinoma Treated Medically.
    Minns RM; Barranco-Trabi J; Yiu AC; Hussain A; Elegino-Steffens DU
    Mil Med; 2023 May; 188(5-6):1304-1306. PubMed ID: 35758408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The assessment of cabergoline efficacy and tolerability in patients with pituitary prolactinoma type.
    Bolko P; Jaskuła M; Waśko R; Wołuń M; Sowiński J
    Pol Arch Med Wewn; 2003 May; 109(5):489-95. PubMed ID: 14768178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia.
    Colao A; Di Sarno A; Cappabianca P; Di Somma C; Pivonello R; Lombardi G
    N Engl J Med; 2003 Nov; 349(21):2023-33. PubMed ID: 14627787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolactinomas and the eye: a clinical case and review.
    Sink M; Chou J
    Optom Vis Sci; 2012 Nov; 89(11):e85-94. PubMed ID: 23034337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia.
    Colao A; Sarno AD; Cappabianca P; Briganti F; Pivonello R; Somma CD; Faggiano A; Biondi B; Lombardi G
    Eur J Endocrinol; 2003 Mar; 148(3):325-31. PubMed ID: 12611613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperprolactinaemia in males: a heterogeneous disorder.
    Walsh JP; Pullan PT
    Aust N Z J Med; 1997 Aug; 27(4):385-90. PubMed ID: 9448878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolactinomas in children and adolescents--consequences in adult life.
    Duntas LH
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1227-32; discussion 1261-2. PubMed ID: 11964017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beneficial Effects of High Doses of Cabergoline in the Treatment of Giant Prolactinoma Resistant to Dopamine Agonists: A Case Report with a 21-Year Follow-Up.
    de Castro LF; Magalhães Gonzaga MF; Naves LA; Luiz Mendonça J; Oton de Lima B; Casulari LA
    Horm Res Paediatr; 2018; 89(1):63-70. PubMed ID: 28954263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report.
    Casulari LA; de Castro LF; Kessler IM; Mendonça JL; de Fátima Magalhães Gonzaga M
    J Med Case Rep; 2019 Jun; 13(1):183. PubMed ID: 31202268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Case Report: Multiple prolactinomas in a young man with Kallmann syndrome and familial hypocalciuric hypercalcemia.
    Jensterle M; Janež A; Vipotnik Vesnaver T; Debeljak M; Breznik N; Trebušak Podkrajšek K; Herman R; Fliers E; Battelino T; Avbelj Stefanija M
    Front Endocrinol (Lausanne); 2023; 14():1248231. PubMed ID: 37964948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Macroadenoma of the pituitary gland with moderate hyperprolactinaemia].
    Harms E; Siggelkow H; Buchfelder M; Saeger W; Hüfner M
    Dtsch Med Wochenschr; 2003 Mar; 128(13):667-70. PubMed ID: 12660899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Syndrome of inappropriate antidiuretic hormone with recurrent giant cabergoline-resistant prolactinoma.
    Kanzaki A; Kadoya M; Katayama S; Koyama H
    BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37770242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lesson to be remembered from a skull base tumor.
    Briet C; Bernard F; Rodien P
    Neurochirurgie; 2017 Sep; 63(4):334-335. PubMed ID: 28882600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy.
    Tyson D; Reggiardo D; Sklar C; David R
    Am J Dis Child; 1993 Oct; 147(10):1057-61. PubMed ID: 8213676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolactinoma presenting as painful postganglionic Horner syndrome.
    Talkad AV; Kattah JC; Xu MY; Orth EH; Chang JY
    Neurology; 2004 Apr; 62(8):1440-1. PubMed ID: 15111696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.